Skip to main content
. 2022 Jan 31:10.2217/fvl-2021-0066. doi: 10.2217/fvl-2021-0066

Figure 4. Forest plot for the pooling of mean differences for length of stay.

Figure 4.

The use of LPV/r was compared with control groups using standard of care or adjuvant therapies without LPV/r. Heterogeneity was quantified using I2 statistics. MD < 0 indicates beneficial treatment effects of LPV/r compared with the control groups.

HCQ: Hydroxychloroquine; LPV/r: Lopinavir–ritonavir; MD: Mean difference.